THY1 and glomerulonephritis: Given that impairment of cGMP-signalling leads to anti-thy1 glomerulonephritis [65], and the cGMP-signal transduction pathway has been shown to abate inflammation [66], the enhancement of ANP and cGMP by hemin may counter-regulate the effects of elevated renal inflammation to improve renal function.